 | |
| Clinical data | |
|---|---|
| Trade names | Choloxin |
| Other names | D-3,5,3',5'-tetraiodothyronine |
| AHFS/Drugs.com | Multum Consumer Information |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.094  |
| Chemical and physical data | |
| Formula | C15H11I4NO4 |
| Molar mass | 776.874 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dextrothyroxine (trade name Choloxin) is a dextrorotary isomerofthyroxine.[1] It saw research as a cholesterol-lowering drug[2] but was pulled due to cardiac side-effects. It increases hepatic lipase which in turn improves utilization of triglycerides and decreases levels of lipoprotein(a)inblood serum.[3]
|
| |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GI tract |
| ||||||||||||
| Liver |
| ||||||||||||
| Blood vessels |
| ||||||||||||
| Combinations |
| ||||||||||||
| Other |
| ||||||||||||
| |||||||||||||
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Receptor (ligands) |
| ||||||||
| Transporter (blockers) |
| ||||||||
| Enzyme (inhibitors) |
| ||||||||
| Others |
| ||||||||
| |||||||||
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
